NPs Basic Information

Name
Caryophyllene oxide
Molecular Formula C15H24O
IUPAC Name*
(1R,4R,6R,10S)-4,12,12-trimethyl-9-methylidene-5-oxatricyclo[8.2.0.04,6]dodecane
SMILES
C[C@@]12CC[C@@H]3[C@H](CC3(C)C)C(=C)CC[C@H]1O2
InChI
InChI=1S/C15H24O/c1-10-5-6-13-15(4,16-13)8-7-12-11(10)9-14(12,2)3/h11-13H,1,5-9H2,2-4H3/t11-,12-,13-,15-/m1/s1
InChIKey
NVEQFIOZRFFVFW-RGCMKSIDSA-N
Synonyms
Caryophyllene oxide; (-)-Caryophyllene oxide; 1139-30-6; beta-Caryophyllene oxide; beta-Caryophyllene epoxide; (-)-Epoxycaryophyllene; (-)Carophyllene oxide; trans-caryophyllene oxide; Epoxycaryophyllene; CHEMBL508894; S2XU9K448U; CHEBI:67818; .beta.-Caryophyllene oxide; (1R,4R,6R,10S)-4,12,12-trimethyl-9-methylidene-5-oxatricyclo[8.2.0.04,6]dodecane; (-)-Epoxydihydrocaryophyllene; Caryophyllene Oxide 1000 microg/mL in Isopropanol; (-)-.beta.-Caryophyllene epoxide; (-)-BETA-CARYOPHYLLENE EPOXIDE; (1R,4R,6R,10S)-4,12,12-TRIMETHYL-9-METHYLIDENE-5-OXATRICYCLO[8.2.0.0?,?]DODECANE; 5-Oxatricyclo(8.2.0.0(4,6))dodecane, 4,12,12-trimethyl-9-methylene-, (1R,4R,6R,10S)-; 5-Oxatricyclo(8.2.0.04,6)dodecane, 4,12,12-trimethyl-9-methylene-, (1R,4R,6R,10S)-; MFCD00134216; UNII-S2XU9K448U; HSDB 5466; EINECS 214-519-7; trimethyl(methylene)[?]; DSSTox_CID_30138; DSSTox_GSID_51586; CARYOPHYLLENE, EPOXIDE; SCHEMBL127077; DTXSID4051586; FEMA NO. 4085; (-)-Caryophyllene oxide, 95%; HY-N3544; ZINC2083320; Tox21_303807; 4,11,11-Trimethyl-8-methylene-5-oxatricyclo(8.2.0.0(4,6))dodecane; BDBM50241720; s3983; AKOS030241571; CCG-208462; 4,12,12-Trimethyl-9-methylene-5-oxatricyclo(8.2.0.04,6)dodecane, (1R,4R,6R,10S)-; NCGC00357089-01; AS-58060; .BETA.-CARYOPHYLLENE OXIDE [FHFI]; CAS-1139-30-6; 4.BETA.,5.ALPHA.-EPOXYCARYOPHYLLENE; CS-0023810; CARYOPHYLLENE 4.BETA.,5.ALPHA.-OXIDE; (-)-BETA-CARYOPHYLLENE EPOXIDE [HSDB]; C16908; CARYOPHYLLENE 4.BETA.,5.ALPHA.-EPOXIDE; E80731; SR-05000002236; SR-05000002236-2; W-108611; (-)-Caryophyllene oxide, analytical reference material; (1R,4R,5R,9S)-4,5-epoxycaryophyllan-8(13)-ene; Q27136294; (-)-Caryophyllene oxide, >=99.0% (sum of enantiomers, GC); (1R,4R,6R,10S)-9-Methylene-4,12,12-trimethyl-5-oxatricyclo[8.2.0.0(4,6])dodecane; 4-12,12-TRIMETHYL-9-METHYLENE-5-OXATRICYLO (8.2.0.04,6) DODECANE; (1R-(1R*,4R*,6R*,10S*))-4,12,12-Trimethyl-9-methylene-5-oxatricyclo(8.2.0.04,6)dodecane; 105120-46-5; 5-Oxatricyclo(8.2.0.0(sup 4,6))dodecane, 4,12,12-trimethyl-9-methylene-, (1R,4R,6R,10S)-; 5-OXATRICYCLO(8.2.0.04,6)DODECANE, 4,12,12-TRIMETHYL-9-METHYLENE-, (1R-(1R*,4R*,6R*,10S*))-
CAS 1139-30-6
PubChem CID 1742210
ChEMBL ID CHEMBL508894
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Sesquiterpenoids
          • Direct Parent: Sesquiterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 220.35 ALogp: 3.6
HBD: 0 HBA: 1
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 12.5 Aromatic Rings: 3
Heavy Atoms: 16 QED Weighted: 0.43

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.673 MDCK Permeability: 0.00002050
Pgp-inhibitor: 0.001 Pgp-substrate: 0
Human Intestinal Absorption (HIA): 0.003 20% Bioavailability (F20%): 0.338
30% Bioavailability (F30%): 0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.249 Plasma Protein Binding (PPB): 82.27%
Volume Distribution (VD): 1.279 Fu: 18.29%

ADMET: Metabolism

CYP1A2-inhibitor: 0.172 CYP1A2-substrate: 0.549
CYP2C19-inhibitor: 0.177 CYP2C19-substrate: 0.916
CYP2C9-inhibitor: 0.267 CYP2C9-substrate: 0.383
CYP2D6-inhibitor: 0.016 CYP2D6-substrate: 0.809
CYP3A4-inhibitor: 0.077 CYP3A4-substrate: 0.339

ADMET: Excretion

Clearance (CL): 6.458 Half-life (T1/2): 0.17

ADMET: Toxicity

hERG Blockers: 0.046 Human Hepatotoxicity (H-HT): 0.281
Drug-inuced Liver Injury (DILI): 0.397 AMES Toxicity: 0.014
Rat Oral Acute Toxicity: 0.071 Maximum Recommended Daily Dose: 0.816
Skin Sensitization: 0.413 Carcinogencity: 0.149
Eye Corrosion: 0.597 Eye Irritation: 0.774
Respiratory Toxicity: 0.873
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001297 0.527 D0C7JF 0.293
ENC001630 0.491 D0L2LS 0.282
ENC001565 0.491 D0D2VS 0.280
ENC001563 0.491 D0U3GL 0.280
ENC001826 0.491 D0Z1XD 0.280
ENC002256 0.450 D04VIS 0.273
ENC001663 0.441 D0S3WH 0.266
ENC002543 0.441 D0H1QY 0.259
ENC002110 0.393 D0K0EK 0.256
ENC003084 0.393 D06XMU 0.256
*Note: the compound similarity was calculated by RDKIT.